Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Life (Basel, Switzerland)|March 29, 2023
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These TumorsFiona O'Neill, Taylor-Jade Allen-Coyle, Sandra Roche, et al.
The Lancet. Oncology|January 9, 2013
2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trialPirkko-Liisa Kellokumpu-Lehtinen, Ulrika Harmenberg, Timo Joensuu, et al.
The Oncologist|May 10, 2022
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland CancersXiuning Le, Christina Baik, Jessica Bauman, et al.
European Urology Oncology|May 3, 2026
Pembrolizumab Plus Lenvatinib in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort EMarinela Augustin, Brigitte Laguerre, Capucine Baldini, et al.
European Journal of Endocrinology|March 25, 2022
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinomaSteven G Waguespack, Alexander Drilon, Jessica J Lin, et al.
Endocrine-Related Cancer|July 15, 2026
Larotrectinib in TRK fusion differentiated thyroid carcinoma: updated trial dataSteven G Waguespack, Marcia S Brose, Jessica J Lin, et al.
Trials|October 6, 2017
The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trialGráinne Sheill, Lauren Brady, Emer Guinan, et al.
Cancers|July 26, 2020
Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials IrelandCathriona Kearns, Ronan Feighery, John Mc Caffrey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2018
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal CancerMichael J Overman, Sara Lonardi, Ka Yeung Mark Wong, et al.
Acta Oncologica (Stockholm, Sweden)|May 3, 2024
Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)Sampsa Kinos, Helga Hagman, Päivi Halonen, et al.
Pageof 10